Demo Data from VLDB 2026 / reviewers in the wild / expert
Peter Tcherveniakov
dblp:166/8720
· DBLP profile ↗
1ranked-venue papers
0as first author
0since 2021 · last 2015
—ORCID · unresolved
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 3 heaviest of 3, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology
cancer genomics |
0.2 | 1 | 2015 | Stratifying tumour subtypes based on copy number alteration profiles using next-generation sequence data · Bioinform. 2015 |
Bioinformatics and computational biology › cancer genomics › cancer subtype analysis
cancer subtype classification |
0.2 | 1 | 2015 | Stratifying tumour subtypes based on copy number alteration profiles using next-generation sequence data · Bioinform. 2015 |
Bioinformatics and computational biology › cancer genomics › copy number analysis
copy number alteration analysis |
0.2 | 1 | 2015 | Stratifying tumour subtypes based on copy number alteration profiles using next-generation sequence data · Bioinform. 2015 |
Methods — techniques the papers use, named apart from their topics
mixed model · 0.2logistic regression · 0.2cross-validation · 0.2
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2015 | Stratifying tumour subtypes based on copy number alteration profiles using next-generation sequence dataabstractMOTIVATION: The role of personalized medicine and target treatment in the clinical management of cancer patients has become increasingly important in recent years. This has made the task of precise histological substratification of cancers crucial. Increasingly, genomic data are being seen as a valuable classifier. Specifically, copy number alteration (CNA) profiles generated by next-generation sequencing (NGS) can become a determinant for tumours subtyping. The principle purpose of this study is to devise a model with good prediction capability for the tumours histological subtypes as a function of both the patients covariates and their genome-wide CNA profiles from NGS data. RESULTS: We investigate a logistic regression for modelling tumour histological subtypes as a function of the patients' covariates and their CNA profiles, in a mixed model framework. The covariates, such as age and gender, are considered as fixed predictors and the genome-wide CNA profiles are considered as random predictors. We illustrate the application of this model in lung and oral cancer datasets, and the results indicate that the tumour histological subtypes can be modelled with a good fit. Our cross-validation indicates that the logistic regression exhibits the best prediction relative to other classification methods we considered in this study. The model also exhibits the best agreement in the prediction between smooth-segmented and circular binary-segmented CNA profiles. AVAILABILITY AND IMPLEMENTATION: An R package to run a logistic regression is available in http://www1.maths.leeds.ac.uk/~arief/R/CNALR/. CONTACT: [email protected] SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Arief Gusnanto, Peter Tcherveniakov, Farag Shuweihdi, Manar Samman, Pamela Rabbitts, Henry M. Wood |
Bioinform. | 2 |